Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology ...

We believe our approach to preserving lean muscle mass with our highly selective novel anti-myostatin SRK-439 when used with a GLP-1 receptor agonist can preserve ... This also includes working with ...

Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an ...

Stifel Nicolaus analyst Selman Akyol maintained a Buy rating on Global Partners (GLP – Research Report) today and set a price target of $54.00. The company’s shares closed yesterday at $49.27.

Stifel analyst Selman Akyol raised the firm’s price target on Global Partners (GLP) to $54 from $51 and keeps a Buy rating on the shares.

While much of the hedge funds industry is hemorrhaging cash, some firms are facing a problem of plenty in a year shaping up to be one of their best in at least a decade. Ilex Capital Partners, one of ...

To accelerate the growth of its activities, BNP Paribas Investment Partners will: rebrand as BNP Paribas Asset Management (BNPP AM), as of 1 June, in order to support its strategy and a simpler ...

Amid fears of an "extremely high level of violent protests," the Brampton Triveni Mandir and Community Centre has cancelled a Life Certificate Event.